Recorlev - NDC Database

1 record found
Page:1
72065-003 Dec 30, 2021
Recorlev 150 mg Oral Tablet by Xeris Pharmaceuticals, Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.